As Life Sciences companies prepare for an unprecedented number of product launches over the next five years, they should adopt an integrated, forward-looking model that leverages a robust technology stack, including data management systems, CRM platforms, marketing automation tools, and AI-driven decision-making engines.
This paper discusses a model designed to assure the success of individual product launches through AI-driven omnichannel customer journey management (physician, patient, hospital systems, etc.) with integrated cross-functional efforts (clinical, medical, commercial, access, patient services, etc.) that enable scalable learning across launches.
Key Components of the Model
1. Pre-Launch Preparedness
Integrated Data Insights: Integrate healthcare provider (HCP), healthcare organization (HCO) and patient-centric data captured from clinical through commercial stages of assets. Utilize AI to optimize stakeholder engagement through all clinical and commercial phases to accelerate clinical trial operations, scientific information dissemination and consumption, and HCP targeting, for precise segmentation and journey mapping.
Cross-Functional Alignment: Use CRM and automation tools to align R&D, marketing, sales, medical, market access, and patient services teams, for realtime feedback and HCP-centric engagement strategy adjustments at scale.
Stakeholder Engagement: Engage key opinion leaders (KOLs) and patient communities across channels with personalized content at scale early to build advocacy networks, fostering trust and support for launches.
2. Launch Execution
Omnichannel Orchestration: Deploy tools like Aktana’s platform to dynamically refine targeting and segmentation, maximizing reach, and effectiveness.
HCP Engagement and Education: Personalize educational content design and delivery using AI driven insights for timely, relevant interactions with HCPs. Track consumption of educational content and corresponding HCP journey progression to inform downstream content creation and optimize crossfunctional engagement strategies.
Adaptive Marketing Tactics: Implement AI-driven feedback loops to continuously optimize messaging and delivery for alignment with market needs.
3. Post-Launch Optimization
Ongoing Performance Tracking: Establish a framework for real-time monitoring of KPIs for continuous strategy adjustments.
Scalability and Learnings: Create processes for capturing insights from each launch and applying them to future efforts for continuous improvement.
Sustained Engagement: Maintain HCP engagement through personalized, ongoing communications, driving long-term brand adoption. Manage portfolio strategies to drive adoption of all products while minimizing customer fatigue.
4. Portfolio Management
Cross-functional effort alignment: Align customer facing strategies and tactics across functions to deliver a seamless experience to customers along their learning journeys across the portfolio.
Centralized Launch Coordination: Implement a centralized digital hub to oversee all launch activities, for integration with other portfolio products and alignment of priorities across the portfolio.
Scalable Omnichannel Orchestration: Use dynamic segmentation and automated campaign execution to manage multiple launches simultaneously.
Continuous Learning Framework: Standardize post-launch reviews and leverage AI for pattern recognition to improve future strategies.
Flexible Resource Allocation: Monitor and reallocate resources in real-time based on evolving launch needs and priorities.
Portfolio-Level Performance Tracking: Develop a unified dashboard for realtime insights and executive-level reporting on launch performances.
Conclusion
By adopting this comprehensive model, Life Sciences companies will be well-positioned to set a new industry standard for product launches. This approach ensures individual launch successes and also fosters a scalable framework for continuous improvement, driving sustained growth and innovation across product portfolios in the coming years.
